p-Coumaric Acid Attenuates Cardiac Fibrosis via AMPK-Associated Paracrine Crosstalk Between Fibroblasts and Endothelial Cells
Diabetic cardiomyopathy (DCM) is characterized by cardiac fibrosis and adverse remodeling, for which effective targeted therapies remain lacking. Previously, p-coumaric acid (PCA), a phenolic compound found in Phoenix dactylifera and Beta vulgaris, was demonstrated by us as having antihyperglycemic and antifibrotic potential, but its mechanism of action and effects on cardiac cell crosstalk remained unexplored. Recently, we investigated the possibility that antifibrotic effects of PCA on cardiac fibroblasts might be observed through AMPK-associated regulation of the PPAR-α/MAPK pathway and possible paracrine effects on cardiomyocytes and endothelial cells. For this purpose, human cardiac fibroblasts (HCFs) were cultured under glycemic and fibrotic conditions with or without PCA treatment, and cells were exposed to compound C to block AMPK. Afterwards, conditioned media was collected from these cells and applied to human umbilical vein endothelial cells (HUVECs) and AC16 cardiomyocytes. Our results showed that PCA significantly decreased the gene and protein expression levels of CTGF and α-SMA in HCFs, confirming its antifibrotic effects even in the presence of compound C (a potent AMPK inhibitor). Mechanistically, PCA partly modulated AMPK levels, which further upregulated levels of PPAR-α and downregulated MAPK levels. Moreover, conditioned media-treated HUVECs showed a significantly improved p-eNOS/e-NOS ratio, a molecular change associated with improved endothelial function through paracrine effects. In AC16 cardiomyocytes, there was significant reduction in troponin levels while AMPK and PPAR-α were upregulated. These findings demonstrated that PCA exerts its antifibrotic effects partly through the AMPK-associated pathway and also confers protective paracrine effects on endothelial cells and cardiomyocytes, suggesting its significant potential in DCM-associated cardiac remodeling.
Authors
- Laaraib Nawaz (ORCID: https://orcid.org/0000-0002-9420-632X)
- Hussam Daghistani (ORCID: https://orcid.org/0000-0001-8491-8350)
- Shahzad Irfan (ORCID: https://orcid.org/0000-0003-3260-4215)
- David Grieve (ORCID: https://orcid.org/0000-0002-3655-7754)
- Kevin S. Edgar (ORCID: https://orcid.org/0000-0002-8057-0104)
- Mohammed H. Alsaggaf (ORCID: https://orcid.org/0009-0002-0934-1226)
Institutions
- Queen's University Belfast (GB)
- University of Lahore (PK)
- King Abdulaziz University (SA)
- Government College University, Faisalabad (PK)
Publication Details
- Journal
- Cells
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/cells15222089
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 0.00